Profile
Full Name
Anebulo Pharmaceuticals, Inc.Ticker
NASDAQ: ANEBExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 7, 2021Indexes
Not includedWebsite
http://www.anebulo.comEmployees
2Key Details
Price
$3.10(-1.27%)
Market cap
$127.36M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.32(+31.91% YoY)
PE ratio
-
Next earnings date
Sep 25, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Anebulo Pharmaceuticals, Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jul 23, 25 Maxim Group
HoldMay 15, 25 Maxim Group
BuyNov 19, 24 Benchmark
Speculative BuyOct 1, 24 Benchmark
Speculative BuyOct 3, 23 Benchmark
Speculative BuySep 25, 23 HC Wainwright & Co.
BuySep 21, 23 Maxim Group
BuySep 18, 23 HC Wainwright & Co.
BuyMay 18, 23 Benchmark
Speculative BuyFeb 14, 23 Benchmark
Speculative BuyInstitutional Ownership
- What is the ticker symbol for Anebulo Pharmaceuticals, Inc.?
- Does Anebulo Pharmaceuticals, Inc. pay dividends?
- What sector is Anebulo Pharmaceuticals, Inc. in?
- What industry is Anebulo Pharmaceuticals, Inc. in?
- What country is Anebulo Pharmaceuticals, Inc. based in?
- When did Anebulo Pharmaceuticals, Inc. go public?
- Is Anebulo Pharmaceuticals, Inc. in the S&P 500?
- Is Anebulo Pharmaceuticals, Inc. in the NASDAQ 100?
- Is Anebulo Pharmaceuticals, Inc. in the Dow Jones?
- When was Anebulo Pharmaceuticals, Inc.'s last earnings report?
- When does Anebulo Pharmaceuticals, Inc. report earnings?
What is the ticker symbol for Anebulo Pharmaceuticals, Inc.?
The ticker symbol for Anebulo Pharmaceuticals, Inc. is NASDAQ:ANEB
Does Anebulo Pharmaceuticals, Inc. pay dividends?
No, Anebulo Pharmaceuticals, Inc. does not pay dividends
What sector is Anebulo Pharmaceuticals, Inc. in?
Anebulo Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Anebulo Pharmaceuticals, Inc. in?
Anebulo Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Anebulo Pharmaceuticals, Inc. based in?
Anebulo Pharmaceuticals, Inc. is headquartered in United States
When did Anebulo Pharmaceuticals, Inc. go public?
Anebulo Pharmaceuticals, Inc.'s initial public offering (IPO) was on May 7, 2021
Is Anebulo Pharmaceuticals, Inc. in the S&P 500?
No, Anebulo Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Anebulo Pharmaceuticals, Inc. in the NASDAQ 100?
No, Anebulo Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Anebulo Pharmaceuticals, Inc. in the Dow Jones?
No, Anebulo Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Anebulo Pharmaceuticals, Inc.'s last earnings report?
Anebulo Pharmaceuticals, Inc.'s most recent earnings report was on May 13, 2025
When does Anebulo Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Anebulo Pharmaceuticals, Inc. is September 25, 2025